Malaria

Researchers have found that inflammation leads to changes in the makeup of blood plasma that slow the growth of the parasites that cause malaria. They hope their discovery may one day be used to control or even prevent the disease.

Environmental modification has a flow-on effect on natural ecosystems, including the insects that carry disease. For the first time, researchers have shown how environmental change affects the transmission of insect-borne diseases.

For studies on insect-borne diseases, many a human has sacrificed an arm in a tank full of mosquitos. Now, a new artificial skin filled with real blood might spare humans the itchy bites, while providing a greater insight into mosquito behavior.

While it's very important to track malaria infections in at-risk populations, drawing and analyzing blood samples can be problematic. A new device is designed to help, as it uses light to detect the disease within a matter of seconds.

In the first big real-world test for monoclonal antibodies against malaria a new study has reported extraordinarily promising results, with a novel therapy found to be 88.2% effective at preventing infections across a six-month period.

When it comes to keeping mosquitoes from spreading malaria, some approaches involve killing the insects, or stopping them from acquiring malaria parasites. A new method, however, stunts the growth of the parasites once they're in the mosquito's gut.

Promising results from a Phase 1 human trial testing a novel monoclonal antibody treatment designed to prevent malaria infection reveal almost every volunteer resisted infection after being deliberately exposed to malaria.

Scientists have discovered a highly-promising new weapon that could help counter drug-resistant malaria, demonstrating how a compound can stealthily infiltrate the parasite and causes it to self-destruct.

In many regions, insecticide-impregnated bed nets are utilized not just to keep malaria-carrying mosquitoes from biting, but also to kill them. A new study shows that such nets could be much more effective if a different type of chemical were used.

For many years now, people in parts of Africa have used a tea made from the leaves of a certain plant to treat malaria. Scientists recently identified the active ingredient, and believe that it could be used in alternative treatments for the disease.

Following a successful pilot study encompassing nearly one million children the World Health Organization is now recommending widespread use of the world's first malaria vaccine across all sub-Saharan Africa.

BioNTech, the pioneering mRNA company responsible for one of the world’s first COVID-19 vaccines, is now looking to develop an mRNA malaria vaccine. Working with the World Health Organization the company hopes to begin human trials sometime next year.